.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have developed a groundbreaking Roxithromycin detection biosensor that utilizes a target-induced DNA nanodevice. This system combines a regenerable Surface-Enhanced Raman Scattering (SERS) substrate with an advanced signal amplification strategy. Consequently, the sensor addresses common limitations such as substrate waste and poor detection stability. Additionally, the integration of these technologies ensures an ultrasensitive platform for clinical and pharmaceutical applications.
The core of this innovation involves the HOF@Au substrate, which researchers engineered by reducing gold nanoparticles on alkali-resistant HOF-102. Furthermore, the team designed a DNA triplex structure that responds directly to pH levels. When the target antibiotic is present, the specific aptamer activates a DNAzyme. This interaction triggers a series of cleavage and rolling-assembly cycles. Therefore, this cascade system amplifies the Raman signal significantly. This mechanism allows for the precise quantification of trace drug levels in various samples.
The proposed strategy demonstrates a remarkable limit of detection at 3.97 × 10-14 mol/L. Notably, the system is fully regenerable due to the pH-responsive nature of the DNA structure. By modulating pH, the triplex structure folds or unfolds to allow for the efficient reuse of the SERS substrate. This capability simplifies testing procedures while significantly reducing overall laboratory costs. As a result, this multifunctional platform offers a sustainable model for the future of antibiotic monitoring and biosensing.
The HOF@Au substrate provides a uniform and high-enhancement surface for Raman signals. It is alkali-resistant and regenerable, which makes the detection process more stable and cost-effective than traditional single-use substrates.
The nanodevice uses a target-triggered cycling mechanism involving identifying, cleaving, and rolling-assembly steps. This cascade system amplifies the SERS signal, enabling the sensor to detect trace concentrations of Roxithromycin as low as 3.97 × 10-14 mol/L.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new HOF@Au SERS biosensor with a DNA nanodevice enables ultrasensitive, regenerable detection of Roxithromycin with a detection limit of 3.97 × 10⁻¹⁴ mol/...
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
